在解决临床病理难题的职业生涯中:海德综合征,抗血小板因子4疾病和微血管四肢缺血性亡
1Department of Pathology and Molecular Medicine, and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
International journal of laboratory hematology
|March 3, 2024
概括
血液学实验室解决复杂的病例. 这篇综述详细介绍了关于海德综合征,肝素诱导的血小板缺血症 (HIT) 和四肢瘤的见解,将实验室发现与临床条件联系起来.
科学领域:
- 血液学 血液学 血液学
- 临床病理学 临床病理学
- 免疫生物学的免疫生物学
背景情况:
- 血液学将实验室科学与临床实践相结合.
- 本综述考察了35年来遇到的复杂的血液病状.
- 探讨了关键的临床病理难题,提供了诊断和治疗的见解.
研究的目的:
- 突出实验室洞察力如何解决具有挑战性的临床血液学问题.
- 审查海德综合征和肝素诱导的血小板缺血症 (HIT) 的病理生理学和诊断.
- 讨论HIT及其相关疾病对肢体缺血和危急疾病的影响.
主要方法:
- 案例研究审查和临床病理相关性的分析.
- 实验室发现与临床表现的整合.
- 文献综述和免疫生物学的机制的合成.
主要成果:
- ·维勒布兰德因子 (vWF) 的高分子量多量体的微妙缺陷解释了海德综合征.
- HIT的免疫生物学,包括抗体动态和4Ts评分系统,有助于诊断.
- 非典型的HIT呈现导致在疫苗诱导的免疫血栓性血栓性缺血症 (VITT) 中识别了素独立的抗PF4抗体.
- HIT,华法林和四肢疹之间的关联揭示了促凝剂/抗凝剂不平衡.
结论:
- 实验室调查对于解决复杂的血液学疾病至关重要.
- 了解HIT和相关疾病的免疫生物学可以改善诊断和管理.
- 对凝血和抗凝血的洞察力与重症监护和血管并发症有关.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
Disorders of Hemostasis
904
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
904
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K


